{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:54:25Z","timestamp":1790387665589,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1111\/ajt.15342","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T23:45:42Z","timestamp":1551829542000},"page":"2252-2261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation"],"prefix":"10.1016","volume":"19","author":[{"given":"Rita R.","family":"Alloway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Steve","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Abramowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Castan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian N.","family":"Ilsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Troy","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1111\/ajt.15342_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am J Transplant."},{"issue":"suppl 3","key":"10.1111\/ajt.15342_bib2","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15342_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/tri.13079","article-title":"Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice","volume":"31","author":"Dharnidharka","year":"2018","journal-title":"Transpl Int."},{"issue":"6","key":"10.1111\/ajt.15342_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1159\/000351643","article-title":"Thymoglobulin and its use in renal transplantation: a review","volume":"37","author":"Thiyagarajan","year":"2013","journal-title":"Am J Nephrol."},{"issue":"9","key":"10.1111\/ajt.15342_bib5","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1016\/j.transproceed.2010.08.045","article-title":"Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation","volume":"42","author":"Ciancio","year":"2010","journal-title":"Transplant Proc."},{"issue":"6","key":"10.1111\/ajt.15342_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2215\/CJN.03800415","article-title":"Induction therapy in renal transplantation: why? What agent? What dose? We may never know","volume":"10","author":"Wiseman","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1111\/ajt.15342_bib7","unstructured":"Genzyme Corporation. Thymoglobulin US prescribing information. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/UCM117134.pdf. Accessed 13 June, 2017."},{"issue":"2","key":"10.1111\/ajt.15342_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cct.2013.09.003","article-title":"The ethics of placebo-controlled trials: methodological justifications","volume":"36","author":"Millum","year":"2013","journal-title":"Contemp Clin Trials."},{"issue":"19","key":"10.1111\/ajt.15342_bib9","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1111\/ajt.15342_bib10","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"Noel","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15342_bib11","series-title":"Simulect\u00ae (basiliximab) [package insert]","year":"2003"},{"key":"10.1111\/ajt.15342_bib12","series-title":"Zenapax\u00ae (daclizumab)","year":"1997"},{"issue":"3","key":"10.1111\/ajt.15342_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials."},{"issue":"6","key":"10.1111\/ajt.15342_bib14","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfm873","article-title":"CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A","volume":"23","author":"Abou-Ayache","year":"2008","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"10.1111\/ajt.15342_bib15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients","volume":"67","author":"Brennan","year":"1999","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15342_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.tp.0000165847.05787.08","article-title":"A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring","volume":"80","author":"Ciancio","year":"2005","journal-title":"Transplantation."},{"issue":"20","key":"10.1111\/ajt.15342_bib17","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1111\/ajt.15342_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy","volume":"2","author":"Lebranchu","year":"2002","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15342_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.TP.0000129812.68794.CC","article-title":"Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids","volume":"78","author":"Mourad","year":"2004","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.15342_bib20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/SLA.0000000000000496","article-title":"Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation","volume":"259","author":"Pilch","year":"2014","journal-title":"Ann Surg."},{"issue":"6","key":"10.1111\/ajt.15342_bib21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.TP.0000056635.59888.EF","article-title":"A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients","volume":"75","author":"Charpentier","year":"2003","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15342_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.transproceed.2007.12.016","article-title":"Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection","volume":"40","author":"Khosroshahi","year":"2008","journal-title":"Transplant Proc."},{"issue":"6","key":"10.1111\/ajt.15342_bib23","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","article-title":"Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression","volume":"72","author":"Mourad","year":"2001","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15342_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1399-0012.2009.01127.x","article-title":"A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation","volume":"24","author":"Woodle","year":"2010","journal-title":"Clin Transplant."},{"issue":"16","key":"10.1111\/ajt.15342_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMc0805714","article-title":"Long-term results of rabbit antithymocyte globulin and basiliximab induction","volume":"359","author":"Brennan","year":"2008","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1111\/ajt.15342_bib26","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/ajt.13191","article-title":"Daclizumab versus rabbit antithymocyte globulin in high-risk renal transplants: five-year follow-up of a randomized study","volume":"15","author":"Hellemans","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15342_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13063-015-0891-y","article-title":"Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants","volume":"16","author":"Lentine","year":"2015","journal-title":"Trials."},{"issue":"6","key":"10.1111\/ajt.15342_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.tp.0000282872.17024.b7","article-title":"Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression","volume":"84","author":"Hernandez","year":"2007","journal-title":"Transplantation."},{"issue":"2","key":"10.1111\/ajt.15342_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1399-0012.2007.00774.x","article-title":"A randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in renal transplantation at 24 months of follow-up","volume":"22","author":"Ciancio","year":"2008","journal-title":"Clin Transplant."},{"issue":"1","key":"10.1111\/ajt.15342_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/TP.0b013e3181734b4a","article-title":"Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab\/thymoglobulin: one year follow-up","volume":"86","author":"Ciancio","year":"2008","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15342_bib31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/TP.0b013e318187bc67","article-title":"A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results","volume":"86","author":"Hardinger","year":"2008","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15342_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.TP.0000132329.67611.3F","article-title":"Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation","volume":"78","author":"Hardinger","year":"2004","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.15342_bib33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/01.TP.0000081042.67285.91","article-title":"A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients","volume":"76","author":"Goggins","year":"2003","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15342_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00007890-199807150-00005","article-title":"Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation","volume":"66","author":"Gaber","year":"1998","journal-title":"Transplantation."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15342","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15342","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15342","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522091912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:25:06Z","timestamp":1761629106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522091912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1600613522091912"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15342","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}